These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 26239482)

  • 1. The effect of caffeine and albuterol on body composition and metabolic rate.
    Liu AG; Arceneaux KP; Chu JT; Jacob G; Schreiber AL; Tipton RC; Yu Y; Johnson WD; Greenway FL; Primeaux SD
    Obesity (Silver Spring); 2015 Sep; 23(9):1830-5. PubMed ID: 26239482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.
    Liu AG; Smith SR; Fujioka K; Greenway FL
    Obesity (Silver Spring); 2013 Oct; 21(10):1991-6. PubMed ID: 23686786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
    Ramsey JJ; Colman RJ; Swick AG; Kemnitz JW
    Am J Clin Nutr; 1998 Jul; 68(1):42-51. PubMed ID: 9665095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of caffeine and albuterol on the bronchoconstrictor response to exercise in asthmatic athletes.
    VanHaitsma TA; Mickleborough T; Stager JM; Koceja DM; Lindley MR; Chapman R
    Int J Sports Med; 2010 Apr; 31(4):231-6. PubMed ID: 20148372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
    Toubro S; Astrup AV; Breum L; Quaade F
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
    Molnár D; Török K; Erhardt E; Jeges S
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of thermogenic drugs.
    Astrup A; Toubro S; Christensen NJ; Quaade F
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A; Breum L; Toubro S; Hein P; Quaade F
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies.
    Dulloo AG; Miller DS
    Am J Clin Nutr; 1986 Mar; 43(3):388-94. PubMed ID: 3953478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
    Astrup A; Buemann B; Christensen NJ; Toubro S; Thorbek G; Victor OJ; Quaade F
    Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture.
    Dulloo AG; Miller DS
    J Nutr; 1987 Feb; 117(2):383-9. PubMed ID: 3559753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypothalamic obesity with caffeine and ephedrine.
    Greenway FL; Bray GA
    Endocr Pract; 2008 Sep; 14(6):697-703. PubMed ID: 18996788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
    Buemann B; Marckmann P; Christensen NJ; Astrup A
    Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
    Toubro S; Astrup A; Breum L; Quaade F
    Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
    Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
    Hackman RM; Havel PJ; Schwartz HJ; Rutledge JC; Watnik MR; Noceti EM; Stohs SJ; Stern JS; Keen CL
    Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of adipsin and body composition in the monosodium glutamate (MSG)-treated mouse.
    Spurlock ME; Hahn KJ; Miner JL
    Physiol Behav; 1996 Nov; 60(5):1217-21. PubMed ID: 8916174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine attenuates metabolic syndrome in diet-induced obese rats.
    Panchal SK; Wong WY; Kauter K; Ward LC; Brown L
    Nutrition; 2012 Oct; 28(10):1055-62. PubMed ID: 22721876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
    Daly PA; Krieger DR; Dulloo AG; Young JB; Landsberg L
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S73-8. PubMed ID: 8384187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
    Astrup A; Lundsgaard C
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.